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Angiogenesis, a process which allows the formation of new vessels from pre-existing 
ones, is an essential phenomenon for tumor survival since it allows cancer cells to obtain 
nutrients and oxygen. This explains the increasing interest showed by many groups of 
research and pharmaceutical companies to find compounds with potential to disrupt at 
least one of the steps within the angiogenic process.  
Hydroxytyrosol (3,4-dihydroxyphenyl ethanol) has been identified as the most important 
health-related phenolic compound of virgin olive oil because of its pleiotropic effects on 
multiple targets. In 2012, our group identified hydroxytyrosol as an anti-angiogenic 
compound able to inhibit several key steps in the angiogenic process. In the present study, 
the potential effects of six hydroxytyrosol derivatives are tested and compared with those 
exhibited by hydroxytyrosol by making use of several in vitro and in vivo assays. Results 
indicate that these are candidate new anti-angiogenic compounds with potential utility in 
anti-tumor and anti-angiogenic therapies. 
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